Free Trial

Talkspace (TALK) Competitors

Talkspace logo
$3.02 -0.02 (-0.66%)
As of 01/17/2025 04:00 PM Eastern

TALK vs. PGNY, TDOC, FTRE, NHC, VRDN, AHCO, CDNA, AGL, PNTG, and AVAH

Should you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include Progyny (PGNY), Teladoc Health (TDOC), Fortrea (FTRE), National HealthCare (NHC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), agilon health (AGL), The Pennant Group (PNTG), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry.

Talkspace vs.

Progyny (NASDAQ:PGNY) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, community ranking, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

Progyny has higher revenue and earnings than Talkspace. Talkspace is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Progyny$1.09B1.64$62.04M$0.5836.21
Talkspace$150.04M3.40-$19.18M-$0.01-302.00

Progyny presently has a consensus target price of $25.00, suggesting a potential upside of 19.05%. Talkspace has a consensus target price of $4.38, suggesting a potential upside of 44.87%. Given Talkspace's stronger consensus rating and higher possible upside, analysts clearly believe Talkspace is more favorable than Progyny.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Progyny
0 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.31
Talkspace
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
2 Strong Buy rating(s)
3.00

94.9% of Progyny shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 12.3% of Progyny shares are held by insiders. Comparatively, 21.7% of Talkspace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Progyny has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.

In the previous week, Progyny had 13 more articles in the media than Talkspace. MarketBeat recorded 20 mentions for Progyny and 7 mentions for Talkspace. Progyny's average media sentiment score of 0.62 beat Talkspace's score of 0.37 indicating that Progyny is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Progyny
7 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Talkspace
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Progyny received 95 more outperform votes than Talkspace when rated by MarketBeat users. Likewise, 71.43% of users gave Progyny an outperform vote while only 41.67% of users gave Talkspace an outperform vote.

CompanyUnderperformOutperform
ProgynyOutperform Votes
100
71.43%
Underperform Votes
40
28.57%
TalkspaceOutperform Votes
5
41.67%
Underperform Votes
7
58.33%

Progyny has a net margin of 5.03% compared to Talkspace's net margin of -0.76%. Progyny's return on equity of 11.36% beat Talkspace's return on equity.

Company Net Margins Return on Equity Return on Assets
Progyny5.03% 11.36% 7.87%
Talkspace -0.76%-1.17%-0.99%

Summary

Progyny beats Talkspace on 14 of the 19 factors compared between the two stocks.

Get Talkspace News Delivered to You Automatically

Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TALK vs. The Competition

MetricTalkspaceHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$510.14M$625.40M$5.21B$9.15B
Dividend YieldN/A2.02%5.13%4.03%
P/E Ratio-302.0033.5688.0817.36
Price / Sales3.404.171,243.2778.03
Price / CashN/A23.8143.7535.97
Price / Book4.252.845.314.79
Net Income-$19.18M-$3.80M$122.62M$225.00M
7 Day Performance4.50%-3.19%0.61%2.62%
1 Month Performance1.34%1.43%2.56%3.81%
1 Year Performance26.89%177.38%25.79%20.10%

Talkspace Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TALK
Talkspace
4.3187 of 5 stars
$3.02
-0.7%
$4.38
+44.9%
+26.9%$510.14M$150.04M-302.00500
PGNY
Progyny
4.0794 of 5 stars
$20.30
+8.2%
$25.00
+23.2%
-43.9%$1.73B$1.14B35.00310
TDOC
Teladoc Health
3.3187 of 5 stars
$9.72
-1.5%
$12.24
+25.9%
-55.1%$1.67B$2.59B-1.685,600
FTRE
Fortrea
3.6233 of 5 stars
$18.31
+0.7%
$23.30
+27.3%
-42.3%$1.64B$2.98B-5.3518,000Short Interest ↑
NHC
National HealthCare
N/A$97.01
+0.2%
N/AN/A$1.50B$1.23B12.1612,400
VRDN
Viridian Therapeutics
2.0338 of 5 stars
$17.77
-2.4%
$35.70
+100.9%
-9.8%$1.41B$302,000.00-4.1250
AHCO
AdaptHealth
3.7596 of 5 stars
$10.33
+1.9%
$12.40
+20.0%
+53.1%$1.39B$3.26B-6.2610,700Short Interest ↓
Positive News
CDNA
CareDx
3.8067 of 5 stars
$25.07
+6.1%
$29.60
+18.1%
+131.8%$1.34B$312.78M-9.29740Analyst Revision
Gap Up
High Trading Volume
AGL
agilon health
3.2742 of 5 stars
$2.89
+18.9%
$3.98
+37.8%
-51.2%$1.19B$5.59B-3.07650
PNTG
The Pennant Group
4.0807 of 5 stars
$26.23
+1.6%
$36.00
+37.2%
+74.8%$900.95M$652.30M38.575,791
AVAH
Aveanna Healthcare
0.9068 of 5 stars
$4.44
-1.6%
$4.51
+1.6%
+100.4%$857.92M$1.98B-13.0633,500

Related Companies and Tools


This page (NASDAQ:TALK) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners